Axicabtagene ciloleucel for treating relapsed or refractory follicular lymphoma

Supporting evidence

• Evaluation report

• Appraisal consultation committee papers (PDF 2.73 MB)

  Published:

  07 June 2023

• Final appraisal determination committee papers (PDF 1.67 MB)

  Published:

  07 June 2023